首页> 外国专利> method for the determination of behandlungsparameters a hu00e4mofiltrationsvorrichtung and hu00e4mofiltrationsvorrichtung for application of the procedure

method for the determination of behandlungsparameters a hu00e4mofiltrationsvorrichtung and hu00e4mofiltrationsvorrichtung for application of the procedure

机译:确定该方法中应使用的手部肺参数的方法和适用于该程序的方法

摘要

First and second chambers (103, 104) separated by a semipermeable membrane (102) are parts of an ultrafiltration removal system and an extracorporeal blood circuit respectively. A substitution fluid addition system (107), feeds the extracorporeal circuit. Fluid flow from the first chamber (Qo) is determined. A physical-chemical property Cs1 in the substitution fluid and the corresponding physical-chemical property Cf1 in the fluid removed, are determined. Cs is varied. Corresponding Cs2 properties Cs2 and Cf2 in the substitution fluid and fluid removed, are re-determined. From the values determined for removed fluid flow Qo, properties Cs1, Cs2, Cf1 and Cf2, a treatment parameter is determined. An Independent claim is included for corresponding blood filtration equipment. Preferred Features: Variation in Cs is step-shaped or curved. The treatment parameter is the dialysance of the blood purification element, determined from D = (1 - DELTACf/DELTACs).Qo, where DELTA expresses the measured differences caused by variation in Cs. The treatment parameter is alternatively the blood inlet concentration Cbi. In the extracorporeal circuit, total ultrafiltrate flow Qf withdrawn, and the substitution fluid flow Qs are determined. The flow removed Qo, is determined from their sum. An additional flow of dialysis fluid Qd is provided in the first chamber. The flow removed is determined as the sum of the total ultrafiltrate flow withdrawn (Qf), the substitution fluid flow Qs and the fluid supplied Qd. In addition, the blood flow Qb is determined as the effective blood flow into the blood supply line which can alter the physical-chemical property. Dialysance D1 is determined from the first set of flows, D2 is calculated from a second set, D1 and the first set. Based on numbers of values D1i, taken at various times i during the treatment, and values D2j calculated for various times during treatment, the total treatment coefficient Kt is determined by summing and multiplying by the time differences from prior or subsequent measurement/calculation.
机译:由半透膜(102)隔开的第一腔室(103)和第二腔室(104)分别是超滤去除系统和体外血液回路的一部分。替代流体添加系统(107)为体外回路供血。确定来自第一腔室的流体流量(Qo)。确定替代流体中的物理化学性质Cs1和除去的流体中的相应物理化学性质Cf1。 Cs是多种多样的。重新确定置换液和去除液中的相应Cs2特性Cs2和Cf2。根据为去除的流体流量Qo,特性Cs1,Cs2,Cf1和Cf2确定的值,确定治疗参数。相应的血液过滤设备包括独立索赔。首选功能:Cs的变化是阶梯形或弯曲的。处理参数是血液净化元素的透析度,由D =(1- DELTACf / DELTACs).Qo确定,其中DELTA表示由Cs的变化引起的测量差异。可选地,治疗参数是血液入口浓度Cbi。在体外回路中,总超滤液流量Qf被抽出,替代流体流量Qs被确定。从它们的总和中确定去除的流量Q 0。在第一腔室中提供了额外的透析液流Qd。确定排出的流量为抽取的总超滤液流量(Qf),替代液流量Qs和供应的液流量Qd之和。另外,血流量Qb被确定为进入血液供应管线的可改变物理化学性质的有效血流量。从第一组流动确定透析液D1,从第二组流动D1和第一组计算D2。基于在治疗期间的各个时间i获取的值D1i的数量以及在治疗期间的各个时间计算出的值D2j,通过将总和乘以与先前或随后的测量/计算的时间差来确定总治疗系数Kt。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号